Abstract
The term “perimenopause” refers to the time period when women transition into menopause. Many see the beginning of this transition as when a woman starts to have fluctuating menstrual cycles, which can include amenorrhea for up to 3 months. The perimenopause transition ends, and menopause begins, when a woman has had no menstrual cycles for 12 consecutive months. Many women begin to experience perimenopause in their 40s with average onset of symptoms 4 years prior to menopause. This transition time is often characterized by hormonal fluctuations and oligo-ovulation. The symptoms that can be experienced range from menstrual irregularity and hot flashes to mood changes and genitourinary symptoms. Severity and frequency of symptoms can vary widely from patient to patient. In this chapter, we will discuss some of the most common symptoms that occur during perimenopause and will explore the different options for how each of these symptoms can be managed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008;371(9609):303–14. doi:10.1016/S0140-6736(08)60167-1.
Committee on Gynecologic Practice and the American Society for Reproductive Medicine Practice Committee. Committee Opinion no. 532: Compound Bioidentical Menopausal Hormone therapy. Obster Gynecol 2012.
Committee on Practice Bulletins-Gynecology. Practice, bulletin no 141: management of menopausal symptoms. Obster Gynecol. 2014;123(1):202–16.
Drewe J, Bucher K, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. SpringerPlus. 2015;4(65):1–29. doi:10.1186/s40064-015-0808-y.
Fugate S, Church C. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause. Ann Pharmacother. 2004;38:1482–99. doi:10.1345/aph.1D610.
Hardman S, Gebbie A. Hormonal contraceptive regimens in the perimenopause. Maturitas. 2009;63:204–12. doi:10.1016/j.maturitas.2009.05.001.
Krause M, Nakajima S. Hormonal and nonhormonal treatment of vasomotor symptoms. Obstet Gynecol Clin North Am. 2015;42:163–79. Available from: http://dx.doi.org/10.1016/j.ogc.2014.09.008.
Kaunitz A. Hormonal contraception in women of older reproductive age. N Engl J Med. 2008;358:1262–70. doi:10.1056/NEJMcp0708481.
Mueck A, Seeger H, Rabe T. Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer. 2010;17(4):263–71. doi:10.1677/ERC-10-0076.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland (outside the USA)
About this entry
Cite this entry
Ketch, C., Weedin, E., Gibson, B.A. (2017). Management of the Symptoms of Perimenopause. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-17798-4_44
Download citation
DOI: https://doi.org/10.1007/978-3-319-17798-4_44
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17797-7
Online ISBN: 978-3-319-17798-4
eBook Packages: MedicineReference Module Medicine